Emily M. Leproust
2021
In 2021, Emily M. Leproust earned a total compensation of $1.3M as President, Chief Executive Officer and Chair at Twist Bioscience Corp, a 83% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $615,974 |
---|---|
Salary | $590,083 |
Other | $75,536 |
Total | $1,281,593 |
Leproust received $616K in non-equity incentive plan, accounting for 48% of the total pay in 2021.
Leproust also received $590.1K in salary and $75.5K in other compensation.
Rankings
In 2021, Emily M. Leproust's compensation ranked 7,872nd out of 12,415 executives tracked by ExecPay. In other words, Leproust earned more than 36.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,872 | 37th |
Manufacturing | 3,479 | 37th |
Chemicals And Allied Products | 1,549 | 35th |
Drugs | 1,377 | 34th |
Biological Products, Except Diagnostic Substances | 311 | 31st |
Leproust's colleagues
We found four more compensation records of executives who worked with Emily M. Leproust at Twist Bioscience Corp in 2021.
2021
Patrick Weiss
Twist Bioscience Corp
Chief Operating Officer
2021
James Thorburn
Twist Bioscience Corp
Chief Financial Officer
2021
Patrick Finn
Twist Bioscience Corp
Chief Commercial Officer
2021
William Banyai
Twist Bioscience Corp
Senior Vice President of Advanced Development and General Manager of Data Storage
News
Twist Bioscience Corp CEO Emily Leproust's 2022 pay jumps 362% to $5.9M
January 6, 2023
Twist Bioscience Corp CEO Emily Leproust's 2021 pay falls 83% to $1.3M
January 4, 2022
Twist Bioscience Corp CEO Emily Leproust's 2020 pay slips 8% to $7.4M
January 7, 2021
Twist Bioscience Corp CFO James Thorburn receives $1.5M in 2018
June 14, 2019